These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9578008)

  • 1. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.
    Stecker MM; Kramer TH; Raps EC; O'Meeghan R; Dulaney E; Skaar DJ
    Epilepsia; 1998 Jan; 39(1):18-26. PubMed ID: 9578008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory status epilepticus.
    Fernandez A; Claassen J
    Curr Opin Crit Care; 2012 Apr; 18(2):127-31. PubMed ID: 22322261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus.
    Zhang Q; Yu Y; Lu Y; Yue H
    BMC Neurol; 2019 Apr; 19(1):55. PubMed ID: 30954065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol treatment of refractory status epilepticus: a study of 31 episodes.
    Rossetti AO; Reichhart MD; Schaller MD; Despland PA; Bogousslavsky J
    Epilepsia; 2004 Jul; 45(7):757-63. PubMed ID: 15230698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons.
    Parviainen I; Kälviäinen R; Ruokonen E
    Neurol Res; 2007 Oct; 29(7):667-71. PubMed ID: 18173905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial for the treatment of refractory status epilepticus.
    Rossetti AO; Milligan TA; Vulliémoz S; Michaelides C; Bertschi M; Lee JW
    Neurocrit Care; 2011 Feb; 14(1):4-10. PubMed ID: 20878265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol in the management of refractory status epilepticus: a case report.
    Borgeat A; Wilder-Smith OH; Jallon P; Suter PM
    Intensive Care Med; 1994; 20(2):148-9. PubMed ID: 7755680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol and midazolam in the treatment of refractory status epilepticus.
    Prasad A; Worrall BB; Bertram EH; Bleck TP
    Epilepsia; 2001 Mar; 42(3):380-6. PubMed ID: 11442156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management approaches to prolonged seizures and status epilepticus.
    Bleck TP
    Epilepsia; 1999; 40 Suppl 1():S59-63; discussion S64-6. PubMed ID: 10421562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
    Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D
    Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
    Claassen J; Hirsch LJ; Emerson RG; Mayer SA
    Epilepsia; 2002 Feb; 43(2):146-53. PubMed ID: 11903460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very high dose phenobarbital for refractory status epilepticus.
    Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
    J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU.
    Chiu WT; Campozano V; Schiefecker A; Rodriguez DR; Ferreira D; Headlee A; Zeidan S; Grinea A; Huang YH; Doyle K; Shen Q; Gómez D; Hocker SE; Rohaut B; Sonneville R; Hong CT; Demeret S; Kurtz P; Maldonado N; Helbok R; Fernandez T; Claassen J
    Neurology; 2022 Sep; 99(11):e1191-e1201. PubMed ID: 35918156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus.
    Krishnamurthy KB; Drislane FW
    Epilepsia; 1999 Jun; 40(6):759-62. PubMed ID: 10368075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol versus thiopental sodium for the treatment of refractory status epilepticus.
    Prabhakar H; Bindra A; Singh GP; Kalaivani M
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009202. PubMed ID: 22895985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of severe refractory status epilepticus in children.
    Sahin M; Menache CC; Holmes GL; Riviello JJ
    Epilepsia; 2001 Nov; 42(11):1461-7. PubMed ID: 11879350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Review).
    Prabhakar H; Bindra A; Singh GP; Kalaivani M
    Evid Based Child Health; 2013 Jul; 8(4):1488-508. PubMed ID: 23877948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.